---
title: International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
date: '2024-03-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38531001/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20240327180717&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: 'CONCLUSION: In this comprehensive study of all ages of patients with
  NLPHL, we develop the LP-IPS to identify high-risk patients and inform upcoming
  prospective clinical trials evaluating de-escalation of therapy for patients with
  low LP-IPS scores ...'
disable_comments: true
---
CONCLUSION: In this comprehensive study of all ages of patients with NLPHL, we develop the LP-IPS to identify high-risk patients and inform upcoming prospective clinical trials evaluating de-escalation of therapy for patients with low LP-IPS scores ...